Delivery Order SPE2DB22D3004-SPE2DB25FSG29
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $29,726.93 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $11,378.69 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $9,600.47 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded delivery order was issued with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,279.87 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $22,982.71 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on August 29, 2025, with a completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) valued at $7,179.96. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a single fulfillment action under a larger contracting vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,350.51 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gemtesa 75 mg tablets (90-count). This competitively awarded, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. The contract utilizes no set-aside designation, reflecting the vendor's demonstrated capability to compete in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,253.69 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $88,661.75 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $9,503.28 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSG29Delivery Order
The Defense Logistics Agency awarded a $7,311.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on September 2, 2025, with completion scheduled for September 3, 2025. This non-competitive, competitively awarded delivery order is being performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order under its capacity as a prime contractor within the DLA's Medical Supply Chain operations. This delivery order represents a routine pharmaceutical procurement issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability in delivering diverse pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains to meet the medical procurement requirements of federal defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/2/25 |